37 related articles for article (PubMed ID: 2527097)
21. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
22. [Recent advances in molecular genetics of GM2 gangliosidosis].
Wakamatsu N
Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
[TBL] [Abstract][Full Text] [Related]
23. The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.
Mahuran DJ
Biochim Biophys Acta; 1991 Feb; 1096(2):87-94. PubMed ID: 1825792
[No Abstract] [Full Text] [Related]
24. The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse.
Tifft CJ; Proia RL
Ann Med; 1997 Dec; 29(6):557-61. PubMed ID: 9562524
[TBL] [Abstract][Full Text] [Related]
25. The molecular basis of Tay-Sachs disease: mutation identification and diagnosis.
Mahuran DJ; Triggs-Raine BL; Feigenbaum AJ; Gravel RA
Clin Biochem; 1990 Oct; 23(5):409-15. PubMed ID: 2147596
[TBL] [Abstract][Full Text] [Related]
26. New Approaches to Tay-Sachs Disease Therapy.
Solovyeva VV; Shaimardanova AA; Chulpanova DS; Kitaeva KV; Chakrabarti L; Rizvanov AA
Front Physiol; 2018; 9():1663. PubMed ID: 30524313
[TBL] [Abstract][Full Text] [Related]
27. Late-onset GM2 gangliosidosis and other hexosaminidase mutations among Jews.
Navon R
Adv Genet; 2001; 44():185-97. PubMed ID: 11596983
[No Abstract] [Full Text] [Related]
28. Regulation of GM2 ganglioside metabolism in cultured cells.
Dawson G; Hancock LW; Vartanian T
Chem Phys Lipids; 1986 Dec; 42(1-3):105-16. PubMed ID: 3549015
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.
Riboldi GM; Lau H
Tremor Other Hyperkinet Mov (N Y); 2022; 12():34. PubMed ID: 36618998
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathologies of and enzyme replacement therapies for lysosomal diseases.
Sakuraba H; Sawada M; Matsuzawa F; Aikawa S; Chiba Y; Jigami Y; Itoh K
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):401-13. PubMed ID: 16918392
[TBL] [Abstract][Full Text] [Related]
31. Biosynthesis of normal and mutant beta-hexosaminidases.
Neufeld EF; d'Azzo A
Adv Genet; 2001; 44():165-71. PubMed ID: 11596981
[No Abstract] [Full Text] [Related]
32. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
33. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
35. The biochemical genetics of the hexosaminidase system in man.
Beutler E
Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
[TBL] [Abstract][Full Text] [Related]
36. Biochemistry and genetics of Tay-Sachs disease.
Gravel RA; Triggs-Raine BL; Mahuran DJ
Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
[TBL] [Abstract][Full Text] [Related]
37. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease.
Mahuran DJ
Clin Biochem; 1995 Apr; 28(2):101-6. PubMed ID: 7628066
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
